IPC2022
15th INTERNATIONAL SCIENTIFIC CONFERENCE ON PROBIOTICS, PREBIOTICS, GUT MICROBIOTA AND HEALTH - IPC2022 27-30 June 2022 Carlton Hotel, Bratislava, Slovakia

Prof. Dr. med. Peter C. Konturek

Current affiliation: Director of the Department of Internal Medicine (Gastroenteroogy, Endocrinology and Infectiology), Thuringia Clinic Saalfeld, Teaching Hospital of the University Jena, Germany

Title of your presentation:
Gut Microbiota Liver Axis: from bench to bedside

Biography:
Head of the Department of Internal Medicine (Gastroenterology, Endocrinology and Infectiology) at the Thuringia Clinic Saalfeld, Teaching Hospital of the University of Jena since 2010. Professor of the Internal Medicine and Gastroenterology at the University Erlangen-Nuremberg in Germany. Fellow of the American Association of Gastroenterology (AGAF) and member of the German Association of Gastroenterology (DGVS), Bavarian Association of Gastroenterology (BGFG), German Association of Internal Medicine (DGIM). President of International Microbiota Society. Current research focus: role of gut microbiota in the functional and inflammatory diseases of the gastrointestinal tract and liver diseases: Clinical focus: diagnostic and interventional endoscopy, treatment of IBD and IBS patients. More than 300 original peer-reviewed publications.
Member of the Editorial Board of the World Journal of Gastroenterology, reviewer of the leading gastroenterological journals.
 

Recent publications

How does COVID-19 affect intestinal microbiota?.
Konturek PC.MMW Fortschr Med. 2021 Sep;163(Suppl 5):17-20. doi: 10.1007/s15006-021-0200-5

Food Intolerance of Unknown Origin: Caused by Mucosal Inflammation? A Pilot Study.
Dieterich W, Tietz E, Kohl M, Konturek PC, Rath T, Neurath MF, Zopf Y.Clin Transl Gastroenterol. 2021 Feb 17;12(2):e0031

´Participation of the intestinal microbiota in the mechanism of beneficial effect of treatment with synbiotic Syngut on experimental colitis under stress conditions.
Konturek PC, Konturek K, Brzozowski T, Wojcik D, Magierowski M, Targosz A, Krzysiek-Maczka G, Sliwowski Z, Strzalka M, Magierowska K, Szczyrk U, Kwiecien S, Ptak-Belowska A, Neurath M, Dieterich W, Wirtz S, Zopf Y.J Physiol Pharmacol. 2020 Jun;71(3). doi: 10.26402/jpp.2020.3.03

COVID-19 - more than respiratory disease: a gastroenterologist's perspective.
Konturek PC, Harsch IA, Neurath MF, Zopf Y.J Physiol Pharmacol. 2020 Apr;71(2). doi: 10.26402/jpp.2020.2.02

Intestinal microbiota - a vital "organ" with manifold functions.
Konturek P, Konturek K, Zopf Y, Harsch IA.MMW Fortschr Med. 2020 Mar;162(Suppl 4):9-14. doi: 10.1007/s15006-020-0228-y

From Donor to Patient: Collection, Preparation and Cryopreservation of Fecal Samples for Fecal Microbiota Transplantation.
Nicco C, Paule A, Konturek P, Edeas M. Diseases. 2020 Apr 15;8(2):9. doi: 10.3390/diseases8020009.

Prevalence of antibodies against COVID-19 in the staff of a COVID-19 regular ward.
Harsch IA, Skiba M, Konturek PC, Epstude J.GMS Hyg Infect Control. 2020 May 14;15:Doc09. doi: 10.3205/dgkh000344.

Microbial patterns in patients with histamine intolerance.
Schink M, Konturek PC, Tietz E, Dieterich W, Pinzer TC, Wirtz S, Neurath MF, Zopf Y.J Physiol Pharmacol. 2018 Aug;69(4). doi: 10.26402/jpp.2018.4.09

Gut⁻Liver Axis: How Do Gut Bacteria Influence the Liver?
Konturek PC, Harsch IA, Konturek K, Schink M, Konturek T, Neurath MF, Zopf Y.Med Sci (Basel). 2018 Sep 17;6(3):79. doi: 10.3390/medsci6030079

The Role of Gut Microbiota in Obesity and Type 2 and Type 1 Diabetes Mellitus: New Insights into "Old" Diseases.
Harsch IA, Konturek PC.Med Sci (Basel). 2018 Apr 17;6(2):32. doi: 10.3390/medsci6020032.

Successful therapy of Clostridium difficile infection with fecal microbiota transplantation.
Konturek PC, Koziel J, Dieterich W, Haziri D, Wirtz S, Glowczyk I, Konturek K, Neurath MF, Zopf Y.J Physiol Pharmacol. 2016 Dec;67(6):859-86